Efficacy Study of Pre-emptive Etoricoxib for Postoperative Pain and Functional Outcome in Total Knee Arthroplasty

NCT01246362 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Control
DRUG: Etoricoxib

Sponsor

Singapore General Hospital

Collaborators

[object Object]